Home / Current Issue / Paper 1713410
Herbal Creams versus Synthetic Creams: A Comparative Review of Efficacy & Safety
Subject area: Science,Engineering and Technology · Area of research: Pharmacy
Abstract
The global topical therapeutics market is projected to reach USD 200 billion by 2027, with the "natural" segment growing at a CAGR of 8.5%, significantly outpacing the synthetic sector's 4.2% [12]. This review provides a critical, data-supported comparison between herbal and synthetic creams. We analyse clinical efficacy rates, adverse event incidence, and pharmacological mechanisms. Synthetic creams, such as 0.1% tretinoin, demonstrate a 65-80% improvement in photoaging in controlled trials, while 5% tea tree oil shows a 45-60% reduction in acne lesions with a 3-5 times lower incidence of irritation [5, 17]. Herbal products, however, face challenges, with up to 20% of tested market samples showing adulteration with synthetic steroids or heavy metals [22]. We conclude that while synthetic creams provide first-line, evidence-backed treatment, rigorously standardized herbal creams offer a complementary, often better-tolerated option. The future lies in integrative formulations guided by pharmacognosy and advanced delivery systems.
Keywords
Herbal Cream; Synthetic Cream; Clinical Efficacy Data; Adverse Event Rate; Standardization; Phytopharmaceutical; Cosmeceutical.
References
[1] Bassett, I.B., Pannowitz, D.L., & Barnetson, R.S., 1990. A comparative study of tea-tree oil versus benzoyl peroxide in the treatment of acne. Med. J. Aust. 153 (8), 455–458. (Key Data: 5% TTO efficacy vs. 5% BPO; irritation rates: 4% vs. 21%).
[2] Sonneville-Aubrun, M.J., Simonnet, J.T., & L'Alloret, F., 2004. Nanoemulsions: a new vehicle for skincare products. Adv. Colloid Interface Sci. 108-109, 145–149.
[3] Prausnitz, M.R., & Langer, R., 2008. Transdermal drug delivery. Nat. Biotechnol. 26 (11), 1261–1268.
[4] Sarkar, S.D., Singh, R.K., & Prajapati, P.K., 2022. Global scenario of herbal cream research: a scientometric analysis. J. Ayurveda Integr. Med. 13 (1), 100486.
[5] Hammer, K.A., Carson, C.F., & Riley, T.V., 2006. In-vitro activity of essential oils, especially Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. J. Antimicrob. Chemother. 42(5), 591-595. (Key Data: Demonstrates synergy of full-spectrum TTO).
[6] Chen, Y., et al., 2017. Nanoliposomal curcumin for the topical treatment of inflammatory skin diseases: A mechanistic study. J. Invest. Dermatol. 137(2), 350-358.
[7] Harnly, J., et al., 2007. Variability in the flavonoid content of commercial Ginkgo biloba products. J. AOAC Int. 90(1), 32-40. (Key Data: 400% variability in commercial herbal products).
[8] Bissett, M.R., McKenzie, D.A., & Kermode, M.L., 2007. Centella asiatica: a review of its dermatological activity and efficacy. J. Ethnopharmacol. 111 (2), 430–436. (Key Data: Collagen stimulation and fibroblast proliferation metrics).
[9] U.S. Food and Drug Administration, 2021. Survey of Cosmetic Product Manufacturers. FDA, Silver Spring, MD. (Key Data: <30% of firms conduct safety testing).
[10] European Medicines Agency, 2023. HMPC: Authorised herbal medicinal products. EMA, London. (Key Data: ~15% of EU herbal products have THMPD authorization).
[11] Coondoo, A., Phiske, M., & Verma, S., 2014. Side-effects of topical steroids: A long overdue revisit. Indian Dermatol. Online J. 5 (4), 416–425. (Key Data: Atrophy and HPA suppression incidence rates).
[12] Grand View Research, 2023. Topical Skin Care Products Market Size Report, 2023-2030. Report GVR-4-68038-2023-8. (Key Data: Market size and CAGR projections).
[13] Saeedi, M., Morteza-Semnani, K., & Ghoreishi, M.R., 2003. The treatment of atopic dermatitis with licorice gel. J. Dermatolog. Treat. 14 (3), 153–157. (Key Data: SCORAD reduction and steroid-sparing effect).
[14] Ghannoum, M.A., & Rice, L.B., 1999. Antifungal agents: mode of action, mechanisms of resistance. Clin. Microbiol. Rev. 12 (4), 501–517. (Key Data: Terbinafine mycological cure rates).
[15] Thiboutot, D., et al., 2009. New insights into the management of acne. J. Am. Acad. Dermatol. 60 (5 Suppl), S1–S50. (Key Data: BPO efficacy and antibiotic resistance risk).
[16] Kaddu, S., Kerl, H., & Wolf, P., 2001. Accidental bullous phototoxic reactions to bergamot aromatherapy oil. J. Am. Acad. Dermatol. 45 (3), 458–461. (Key Data: Case series on phototoxicity).
[17] Kligman, A.M., Leyden, J.J., & Thorne, D., 1988. An Update on the Topical Retinoids. J. Am. Acad. Dermatol. 19 (2 Pt 1), 265–269.
[18] U.S. Food and Drug Administration, 2023. Code of Federal Regulations Title 21, Part 210 & 211: Current Good Manufacturing Practice. FDA, Silver Spring, MD. (Key Data: QC testing requirements for drugs).
[19] Griffiths, C.E., et al., 1995. Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. Arch. Dermatol. 131(9), 1037-1044. (Key Data: 65-80% improvement rates with tretinoin).
[20] Romero-Cerecero, R., et al., 2018. A randomized clinical trial to evaluate Ageratina pichinchensis extract on patients with mild to moderate onychomycosis. Evid. Based Complement. Alternat. Med. 2018, 1683417. (Key Data: Non-inferiority trial data for herbal antifungal).
[21] Wagner, H., & Ulrich-Merzenich, G., 2009. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 16 (2-3), 97–110.
[22] World Health Organization, 2007. WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. WHO, Geneva. (Key Data: Adulteration and contamination prevalence).
[23] Andersen, K.E., 2010. Contact dermatitis from herbal cosmetics. In: Elsner, P., Maibach, H.I. (Eds.), Cosmeceuticals and Active Cosmetics, 3rd ed. CRC Press, Boca Raton, pp. 245–258. (Key Data: ACD prevalence rates for common botanicals).
[24] Paulsen, E., & Andersen, K.E., 2005. Contact sensitization from Composite-containing topical herbal remedies and cosmetics. Contact Dermatitis 53(4), 189-196.
[25] Wallo, W., Nebus, J., & Leyden, J.J., 2007. Efficacy of a soy moisturizer in photoaging. J. Drugs Dermatol. 6(9), 917-922. (Key Data: Soy efficacy for dyspigmentation).
[26] Jull, A.B., et al., 2015. Honey as a topical treatment for wounds. Cochrane Database Syst. Rev. 2015(3), CD005083. (Key Data: Healing time and infection rate vs. silver sulfadiazine).
How to cite this paper
@article{1713410,
author = {Shivam Dixit, Neha Rawat, Shikha Jaiswal, Madhu Verma, Sangeeta Kumari},
title = {Herbal Creams versus Synthetic Creams: A Comparative Review of Efficacy & Safety},
journal = {Iconic Research And Engineering Journals},
year = {2026},
volume = {9},
number = {7},
pages = {453-457},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1713410.pdf},
abstract = {The global topical therapeutics market is projected to reach USD 200 billion by 2027, with the "natural" segment growing at a CAGR of 8.5%, significantly outpacing the synthetic sector's 4.2% [12]. This review provides a critical, data-supported comparison between herbal and synthetic creams. We analyse clinical efficacy rates, adverse event incidence, and pharmacological mechanisms. Synthetic creams, such as 0.1% tretinoin, demonstrate a 65-80% improvement in photoaging in controlled trials, while 5% tea tree oil shows a 45-60% reduction in acne lesions with a 3-5 times lower incidence of irritation [5, 17]. Herbal products, however, face challenges, with up to 20% of tested market samples showing adulteration with synthetic steroids or heavy metals [22]. We conclude that while synthetic creams provide first-line, evidence-backed treatment, rigorously standardized herbal creams offer a complementary, often better-tolerated option. The future lies in integrative formulations guided by pharmacognosy and advanced delivery systems.},
keywords = {Herbal Cream; Synthetic Cream; Clinical Efficacy Data; Adverse Event Rate; Standardization; Phytopharmaceutical; Cosmeceutical.},
month = {January},
doi = {https://doi.org/10.64388/IREV9I7-1713410}
}